A newly discovered gene mutation may increase a patient’s risk of genetic heart disease, presenting a target for therapy or genetic screening down the road.
Northwestern Medicine scientists have demonstrated the potential of targeting inflammatory pathways in order to limit tissue damage and improve repair after a heart attack.
The drug idarucizumab rapidly reversed the anticoagulant effects of the blood-thinner dabigatran in emergency situations, according to a recent phase III clinical trial.
An online calculator showed initial success at predicting the risk of heart disease events among young, healthy adults, according to a new study in JAMA Internal Medicine.
Poor sleep may be a significant factor driving the differences in risk of cardiometabolic disease between African-Americans and European-Americans, according to a new study.
Mutations in the genes FOXC2 and GJC2 are associated with defects in venous valves, according to a new study published in the Journal of Experimental Medicine.
Fourth-year medical student Kyle Yoo has been selected as a Fogarty Global Health Fellow and will travel to Kerala, India to study the interplay between management practices and acute cardiac care.
Northwestern Medicine investigators identified key areas of agreement and disagreement between cardiovascular data collected from electronic health records and data gathered in a traditional cohort study.
Northwestern Medicine scientists identified a novel molecular mechanism that regulates scar formation in the heart, a symptom of aging and heart disease.
A new strategy combining five separate tests provided a significantly better risk assessment of cardiovascular disease among adults, compared to traditional measures, according to a study published in Circulation.